Shopping Cart
- Remove All
- Your shopping cart is currently empty
HDAC-IN-4, a selective HDAC6 and HDAC10 inhibitor (pIC50s: 7.2 and 6.8 in the BRET assay), exhibits antitumoral activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $68 | 5 days | |
1 mL x 10 mM (in DMSO) | $161 | 5 days |
Description | HDAC-IN-4, a selective HDAC6 and HDAC10 inhibitor (pIC50s: 7.2 and 6.8 in the BRET assay), exhibits antitumoral activity. |
Targets&IC50 | HDAC6:7.2(pIC50) |
In vitro | HDAC-IN-4 demonstrates superior potency over Tubastatin A in targeting HDAC6, indicating its potential as a more effective HDAC6 probe. Additionally, it exhibits inhibitory effects on HDAC1, HDAC2, HDAC3, HDAC8, and HDAC10, with respective pIC50 values of 5.5, 4.6, 5.4, 5.4, and 6.7 in FRET assays. |
Molecular Weight | 335.4 |
Formula | C20H21N3O2 |
Cas No. | 1252003-13-6 |
Relative Density. | 1.28 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.